振东制药
(300158)
| 流通市值：78.37亿 | | | 总市值：78.41亿 |
| 流通股本：10.05亿 | | | 总股本：10.05亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 439,197,930.42 | 466,171,059.82 | 584,592,028.36 | 371,437,996.8 |
| 交易性金融资产 | 590,670,115.15 | 708,190,826.83 | 989,624,751.22 | 1,408,491,054.32 |
| 应收票据及应收账款 | 783,004,885.35 | 713,549,392.45 | 575,403,850.66 | 756,861,748.07 |
| 其中：应收票据 | 50,437,455.64 | 46,641,522.45 | 55,854,094.12 | 76,430,239.7 |
| 应收账款 | 732,567,429.71 | 666,907,870 | 519,549,756.54 | 680,431,508.37 |
| 应收款项融资 | 76,034,024.45 | 169,722,945.62 | 142,664,197.5 | 95,114,192.62 |
| 预付款项 | 77,380,628.99 | 65,149,815.34 | 66,181,019.8 | 127,241,463.08 |
| 其他应收款合计 | 67,742,197.65 | 73,522,297 | 57,745,074.09 | 87,035,237.01 |
| 存货 | 637,349,919.93 | 643,059,761.36 | 775,978,314.86 | 1,088,764,079.93 |
| 其他流动资产 | 11,698,832.99 | 18,756,297.84 | 23,427,523.51 | 17,529,595.38 |
| 流动资产合计 | 2,683,078,534.93 | 2,858,122,396.26 | 3,215,616,760 | 3,952,475,367.21 |
| 非流动资产: | | | | |
| 长期股权投资 | 28,240,171.19 | 28,631,287.85 | 28,742,700.59 | - |
| 其他权益工具投资 | 9,140,911.21 | 14,909,606.16 | 9,909,606.16 | 87,323,136.76 |
| 投资性房地产 | 14,441,308.12 | 14,060,837.5 | 14,844,321.37 | 14,463,850.75 |
| 固定资产 | 890,752,398.82 | 909,805,743 | 924,468,422.55 | 906,021,262.57 |
| 在建工程 | 144,851,022.54 | 123,021,350.11 | 119,395,906.33 | 100,525,119.99 |
| 生产性生物资产 | - | - | - | 904,962.99 |
| 使用权资产 | 1,977,633.61 | 2,304,607.65 | 2,624,915.68 | 2,013,441.04 |
| 无形资产 | 291,473,670.3 | 283,658,190.63 | 288,845,891.24 | 248,861,831.39 |
| 开发支出 | 97,304,919.82 | 84,816,513.42 | 83,057,493.92 | 207,921,080.07 |
| 商誉 | 15,499,814.18 | 15,499,814.18 | 15,499,814.18 | 40,239,614.18 |
| 长期待摊费用 | 23,251,107.88 | 16,659,493.09 | 18,307,511.85 | 8,922,334.65 |
| 递延所得税资产 | 23,999,578.54 | 25,403,002.07 | 24,966,358.08 | 21,305,348.61 |
| 其他非流动资产 | 274,796,037.72 | 257,685,970.86 | 236,444,843.78 | 290,647,838.45 |
| 非流动资产合计 | 1,815,728,573.93 | 1,776,456,416.52 | 1,767,107,785.73 | 1,929,149,821.45 |
| 资产总计 | 4,498,807,108.86 | 4,634,578,812.78 | 4,982,724,545.73 | 5,881,625,188.66 |
| 流动负债: | | | | |
| 短期借款 | - | 15,252,477.64 | 38,109,647.77 | - |
| 应付票据及应付账款 | 311,942,079.71 | 280,322,055.43 | 328,010,227.32 | 326,030,729.45 |
| 其中：应付票据 | 10,113,790.37 | 19,195,008.23 | 26,254,686.7 | 28,866,631.61 |
| 应付账款 | 301,828,289.34 | 261,127,047.2 | 301,755,540.62 | 297,164,097.84 |
| 合同负债 | 64,736,476.59 | 49,966,144.87 | 51,415,048.96 | 61,271,106.67 |
| 应付职工薪酬 | 22,441,484.76 | 22,327,674.67 | 37,411,874.39 | 27,020,811.55 |
| 应交税费 | 33,786,618.94 | 34,692,008.11 | 14,490,826.56 | 41,881,134.47 |
| 其他应付款合计 | 372,544,219.1 | 529,885,166.4 | 772,222,655.5 | 254,136,112.48 |
| 一年内到期的非流动负债 | 1,783,778.94 | 569,137.95 | 2,012,943.15 | 1,296,190.8 |
| 其他流动负债 | 34,948,236.68 | 11,568,131.51 | 11,362,044.59 | 20,218,896.41 |
| 流动负债合计 | 842,182,894.72 | 944,582,796.58 | 1,255,035,268.24 | 731,854,981.83 |
| 非流动负债: | | | | |
| 租赁负债 | 722,381.07 | 948,216.27 | 1,088,628.95 | 969,791.88 |
| 长期应付款 | 227,773.03 | 27,715,173.03 | 27,715,173.03 | 27,715,173.03 |
| 递延收益 | 37,176,776.19 | 36,655,136.5 | 37,650,654.97 | 39,785,967.42 |
| 递延所得税负债 | 1,096,695.64 | 957,599.45 | 978,553.95 | 1,326,106.67 |
| 非流动负债合计 | 39,223,625.93 | 66,276,125.25 | 67,433,010.9 | 69,797,039 |
| 负债合计 | 881,406,520.65 | 1,010,858,921.83 | 1,322,468,279.14 | 801,652,020.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,005,319,756 | 1,005,319,756 | 1,005,319,756 | 1,005,319,756 |
| 资本公积 | 3,681,716,121.12 | 3,681,733,558.19 | 3,681,733,558.19 | 3,681,733,558.19 |
| 减:库存股 | 51,032,914.41 | 40,381,108.51 | 2,838,312.11 | - |
| 其他综合收益 | -80,925,418.73 | -79,777,530.24 | -79,778,182.56 | -32,403,703.53 |
| 专项储备 | 0 | - | 0 | - |
| 盈余公积 | 481,346,118.6 | 481,346,118.6 | 481,346,118.6 | 481,346,118.6 |
| 一般风险准备 | 0 | - | 0 | - |
| 未分配利润 | -1,380,222,348.74 | -1,386,996,474.81 | -1,388,153,651.67 | -19,466,420.29 |
| 归属于母公司股东权益合计 | 3,656,201,313.84 | 3,661,244,319.23 | 3,697,629,286.45 | 5,116,529,308.97 |
| 少数股东权益 | -38,800,725.63 | -37,524,428.28 | -37,373,019.86 | -36,556,141.14 |
| 股东权益合计 | 3,617,400,588.21 | 3,623,719,890.95 | 3,660,256,266.59 | 5,079,973,167.83 |
| 负债和股东权益合计 | 4,498,807,108.86 | 4,634,578,812.78 | 4,982,724,545.73 | 5,881,625,188.66 |
| 公告日期 | 2025-08-25 | 2025-04-21 | 2025-04-21 | 2024-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |